Table 5

Kinetic analysis of the 4- and 2-hydroxylation of 17β-estradiol by human CYP1B1 variants expressed in S. cerevisiae

CYP1B1 variantAmino acid substitutionsExpression levelKmVmaxVmax/Kmratio
4-Hydroxy2-Hydroxy4-Hydroxy2-Hydroxy4-Hydroxy2-Hydroxy
pmol/mg μM pmol/pmol P450/min
CYP1B1.1None14.65.3  ± 0.38.9  ± 1.13.8  ± 0.10.5  ± 0.100.710.05
CYP1B1.2Arg48Gly, Ala119Ser3.66.4  ± 1.97.7  ± 0.14.7  ± 0.20.5  ± 0.100.730.06
CYP1B1.3Leu432Val;7.16.4  ± 0.28.7  ± 2.43.3  ± 0.20.65  ± 0.100.510.07
CYP1B1.4Asn453Ser5.27.0  ± 1.09.4  ± 1.83.6  ± 0.60.55  ± 0.060.510.06
CYP1B1.6Arg48Gly, Ala119Ser, Leu432Val16.112.1  ± 1.05-b 16.6  ± 0.15-a 2.1  ± 0.15-b 0.3  ± 0.050.175-c 0.015-a
CYP1B1.7Arg48Gly, Ala119Ser, Leu432Val, Ala443Gly7.413.4  ± 1.35-b 39.1  ± 2.45-b 1.7  ± 0.25-b 0.7  ± 0.080.125-c 0.015-b
L432V + N453SLeu432Val, Asn453Ser11.57.9  ± 0.67.5  ± 0.52.6  ± 0.10.3  ± 0.050.320.04
L432V + A443GLeu432Val, Ala443Gly10.08.9  ± 0.69.7  ± 1.73.1  ± 0.10.5  ± 0.100.340.05

Kinetic parameters are presented as means ± S.D. from three independent analyses using two separate microsomal preparations for each enzyme variant.

    • 5-a  Significant difference (p < 0.05) compared with CYP1B1.1 using unpairedt test.

    • 5-b  Significant difference (p < 0.01) compared with CYP1B1.1 using unpairedt test.

    • 5-c  Significant difference (p < 0.001) compared with CYP1B1.1 using unpairedt test.